Held
UMC · United Microelectronic Corp.
Last analysed ·
Against its published line
Nothing is through its line on this close.
How to read this
The red mark is the published kill line — the price that would prove the pick wrong. The dot is where the name closed on 10 September 2026; a dot LEFT of the mark has closed through its line.
Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row stops competing and reads well clear, with a hollow dot to say the figure is off the drawn scale. Rows run tightest first.
Resolved Graded and closed 2026-08-07 at low conviction — the published kill line fired. Coverage continued after the close; the read below is dated 2026-09-10 and is not part of the scored record.
Current thesis
Silicon-photonics pivot re-rated the ADR ~3x, but the July blowoff to $28.96 round-tripped -26% to $21.25 in days while sell-side finally upgraded (Macquarie Outperform 2026-07-14) — late-stage distribution behaviour. The 2026-07-29 Q2 print is now the binary that decides whether the leg resumes or the re-rate unwinds.
Kill line
A weekly close below $19.00 takes out the June breakout shelf and confirms the $28.96 July high as the cycle top; secondarily, a Q2 print on 2026-07-29 that meets revenue but compresses gross margin, showing the mature-node price war reasserting under an AI headline.
Pick status
Invalidated resolved published kill line fired How this is scored →Latest analysis and events for UMC —
As of 10 September 2026, the latest FrontierPicks analysis for United Microelectronic Corp. (UMC): Silicon-photonics pivot re-rated the ADR ~3x, but the July blowoff to $28.96 round-tripped -26% to $21.25 in days while sell-side finally upgraded (Macquarie Outperform 2026-07-14) — late-stage distribution behaviour. The 2026-07-29 Q2 print is now the binary that decides whether the leg resumes or the re-rate unwinds.
Kill line: A weekly close below $19.00 takes out the June breakout shelf and confirms the $28.96 July high as the cycle top; secondarily, a Q2 print on 2026-07-29 that meets revenue but compresses gross margin, showing the mature-node price war reasserting under an AI headline.
Next dated event on file: — catalyst in 3d.
Current Thesis
United Microelectronics Corporation’s recovery thesis requires October results to confirm stronger factory utilization and gross margin before a weekly close below $19.00 breaks the published June breakout shelf. The operating case remains mature-node recovery; silicon photonics adds a commercialization story whose separate revenue contribution is missing from the cited disclosures.
That measured growth supports an inference of improving demand; confirmation requires the October 28 report to meet management’s July 29 guidance for utilization above 90% and gross margin in the mid-30% range. UMC September 4 filing.
The narrative is maturing — the July 14 photonics production announcement was followed by Benzinga’s August 13 coverage of a leveraged UMC fund and August 19 coverage of television commentary. Those dated observations establish wider attention, but the sample is too small to support a claim about crowded ownership.
The September 9 adjusted close advances the price evidence to $22.69. The calendar also becomes more concrete: UMC now schedules September sales for October 6, subject to change, replacing the earlier estimated October 5 date. UMC investor calendar.
Bullish and bearish views on United Microelectronic Corp.
The model's bull view on United Microelectronic Corp. (UMC), in brief: Sales support the recovery case. UMC’s September 4 filing reported August 2026 sales growth of 30.71% year over year and January–August growth of 14.66%. The latest month exceeded the cumulative growth rate, although it does not establish quarterly profitability. UMC September 4… The bear view: Net income includes substantial nonoperating income. Both cases follow in full.
Bull Case
- Sales support the recovery case. UMC’s September 4 filing reported August 2026 sales growth of 30.71% year over year and January–August growth of 14.66%. The latest month exceeded the cumulative growth rate, although it does not establish quarterly profitability. UMC September 4 filing.
- Factory performance has improved. UMC’s July 29 results reported second-quarter 2026 gross margin of 32.5% and utilization of 85%, compared with 29.2% and 79% in the preceding quarter. These reported improvements give the recovery thesis operating evidence beyond the photonics announcement.
- Photonics has a manufacturing milestone. The July 14, 2026 UMC/SILITH announcement described the first mass-production photonic integrated-circuit wafer delivery from Singapore. The milestone establishes production capability; a separate photonics revenue figure was not provided in the cited announcement. UMC announcement index.
Bear Case
- Net income includes substantial nonoperating income. UMC’s July 29 results reported NT$30.236 billion of nonoperating income alongside second-quarter 2026 net income of NT$42.26 billion. Headline net income alone therefore cannot establish the strength of the factory recovery.
- Financing leaves dilution unresolved. The August 26, 2026 board announcement authorized overseas convertible bonds of up to US$1.8 billion with the conversion price unset. The authorization establishes potential equity supply; it does not establish completed issuance or actual hedging activity.
- Momentum exceeds the operating update cadence. The supplied September 9, 2026 adjusted series records a three-month price increase of 21.6% and a 14-session relative strength index of 81.9 points. Neither observation establishes that October’s utilization and margin forecasts will be met.
Setup & Price Structure
The American depositary receipt (ADR) closed at an adjusted $22.69 on September 9, 2026. The same dated series places its 52-week high at $27.65 and its distance below that high at 17.9%. Recent appreciation has therefore left the prior high unrecovered.
The published $19.00 June breakout shelf remains the research invalidation level. A weekly close below $19.00 would end the recovery setup before operating confirmation; the September 9 reference close alone does not establish a new support shelf. No moving-average value accompanies the current price evidence, so distance above a rising average is unquantified.
Positioning evidence remains limited to observable attention and financing events: Benzinga covered the leveraged-fund launch on August 13 and television commentary on August 19, while the convertible authorization followed on August 26. These observations do not measure fund inflows, short covering or the concentration of ownership.
Catalyst Calendar (next 30 days)
- 2026-09-14–2026-09-15 — UBS Taiwan Summit. UMC schedules investor-relations participation in Taipei. The appearance is an opportunity for disclosure, without a promised operating update.
- 2026-10-06 — September sales, tentative. UMC’s scheduled release supplies the final monthly revenue observation for the third quarter.
- 2026-10-28 — Third-quarter results, tentative. Outside the next 30 days, this is the decisive test of July 29 guidance for utilization above 90% and gross margin in the mid-30% range.
Dates and their tentative status come from the UMC investor calendar.
Elapsed catalysts
- 2026-09-10 — Citi GEMs Conference. UMC schedules its chief financial officer’s appearance in New York; no outcome is established in the cited calendar. (passed 1d ago)
What Would Change Our Mind
Loss of the published June breakout shelf would break the price structure: a weekly close below $19.00 invalidates the recovery setup. Independently, an October 28 report that fails either the above-90% utilization guide or the mid-30% gross-margin guide would reject the operating confirmation case established by management on July 29.
The thesis plays out if the October 28 report meets both operating guides before the price invalidation occurs. August’s September 4 sales disclosure supports a medium-conviction forecast, while the unreported third-quarter margin and unresolved August 26 convertible terms limit the evidence.
Correlation Notes
FrontierPicks’ dated foundry-and-equipment theme record moved from maturing on August 30 to saturated on September 6 and remained saturated on September 10, 2026; the named peers are TSM, LRCX and ONTO. That is a group assessment, not a measured return correlation or a finding that UMC’s individual narrative has failed.
The company-specific case remains tied to UMC’s September 4 sales disclosure and July 29 operating guidance. Peer weakness alone would not establish an operating failure; the observable breaks remain the $19.00 weekly-close condition and failure to meet the October operating tests.
Notes
- Each UMC ADS represents five TWSE-listed common shares (2303.TW) and marks off Taiwan's prior close, so US-session gaps carry overnight information.
- 2303.TW trades a ±10% daily price limit the ADR does not; the local line can lock limit-up or limit-down while the ADR keeps trading.
- Taiwan issuers must disclose monthly net sales within the first ten days of the following month, a cadence no US-listed foundry publishes.
- Non-operating investment and dividend income can dominate reported net income: NT$30.236B of NT$42.26B in Q2 2026. Operating margin is the cleaner series.
- Three convertible tranches bear on the share count: NT$12.12B at NT$146.00, NT$4B at NT$130.70, and up to US$1.8B overseas approved 2026-08-26 with the strike unset.
- As a foreign private issuer UMC files 20-F and 6-K, not 10-Q or Form 4, so there is no US insider-transaction record to read against the share price.
Related · shared themes
NVCT
Nuvectis Pharma, Inc.
Nuvectis re-rated on the 2026-06-22 Haisco ex-China in-license and the 2026-07-23 China approval of oral Factor B inhibitor ciprocopan; Nothing binary lands inside 30 days — only conference slots on 09-11 and 09-14, against RSI 72.3 and a 160% three-month advance.
TSEM
Tower Semiconductor Ltd.
Picks-and-shovels photonics foundry where the demand chain keeps beating and the equity has only just begun to follow: the line closed $206.81 on 2026-09-02, reclaiming the $200 shelf, hours before Broadcom guided Q4 AI semiconductor revenue to $21.7B and framed fiscal-2027 AI revenue at approximately $115B. The demand-layer narrative is accelerating while equity confirmation is one session old, with no company-dated number before the ~2026-11-04 Q3 print.
AEHR
Aehr Test Systems
Wafer-level burn-in toll on AI silicon: fiscal 2027 guided $130.0–150.0M against $50.0M in fiscal 2026, unamended on the wire as of 2026-09-03. The unwind paused — $80.24 on 2026-09-02 against $76.59 the prior session, RSI(14) 27.3 from 22.9, still 44.9% under the 52-week high — leaving a saturated narrative with no company-dated catalyst before the 2026-09-10 Lake Street venue and an October print vendor calendars date differently.
AEIS
Advanced Energy Industries, Inc.
Datacenter-power picks-and-shovels re-rating is now fully mainstream — Morgan Stanley initiated Overweight $421 (07-22) atop Wells $465 and Susquehanna $535 — yet the stock fell 12.65% on 07-02 and is sitting on its 200-day while analyst targets keep climbing. Sell-side saturation against a broken tape; the confirmed 2026-08-03 Q2 print is the binary.
See also · stocks to watch